Abstract:SUMMARY Sixteen healthy subjects, ages 18-35 years, were studied in the supine position by means of systolic time intervals and echocardiography before and after smoking a high-nicotine cigarette (2.5 mg nicotine) and a tobacco cigarette of very low nicotine content (< 0.02 mg nicotine) to assess and compare the immediate effects upon left ventricular function.Smokers (n = 12) and nonsmokers (n = 4) behaved alike. High-and low-nicotine cigarettes both caused significant increases in heart rate, systolic and di… Show more
“…Though it has been known that smoking and alcohol predispose to heart failure, [28,29] our data showed no correlation of the above two epidemiological variables with the disease condition. The low percentage of smokers and alcoholics in DCM clearly reß ects a subset of DCMs that are secondary to certain systemic disorders.…”
“…Though it has been known that smoking and alcohol predispose to heart failure, [28,29] our data showed no correlation of the above two epidemiological variables with the disease condition. The low percentage of smokers and alcoholics in DCM clearly reß ects a subset of DCMs that are secondary to certain systemic disorders.…”
“…Cigarette smoking increases heart rate and blood pressure, both principal determinants of myocardial oxygen consumption 14. Goldbarg et al showed in healthy individuals that the left ventricular stroke index decreased significantly at several levels of exercise after smoking, although there was no significant change at rest 15.…”
Section: Precipitating Factors For Relapse Of Congestive Heart Failurementioning
Relapse of congestive heart failure (CHF) frequently occurs and has serious consequences in terms of morbidity, mortality, and health care expenditure. Many studies have investigated the aetiological and prognostic factors of CHF, but there are only limited data on the role of precipitating factors that trigger relapse of CHF. Knowledge of potential precipitating factors may help to optimise treatment and provide guidance for patients with CHF. The literature was reviewed to identify factors that may influence haemodynamic homeostasis in CHF. Precipitating factors that may oVer opportunities for preventing relapse of CHF were selected. Potential precipitating factors are discussed in relation to the pathophysiology of CHF: alcohol, smoking, psychological stress, uncontrolled hypertension, cardiac arrhythmias, myocardial ischaemia, poor treatment compliance, and inappropriate medical treatment. Poor treatment compliance in particular is frequently encountered in patients with CHF. Furthermore, studies of medical treatment under everyday circumstances indicate that some aspects of the management of CHF can be improved. In conclusion, the identification of precipitating factors for relapse of CHF may strongly contribute to optimal treatment. Improvement of treatment compliance and optimalisation of medical treatment may oVer important possibilities to clinicians to reduce the number of relapses in patients with CHF. (Heart 1998;80:432-436) Keywords: congestive heart failure; precipitating factors; prevention There is increasing interest in congestive heart failure (CHF) from both clinicians and researchers. The prevalence of CHF continues to increase despite advances in the treatment of various risk factors for this disease, such as hypertension and coronary artery disease.
1This increase is the result of several medical and demographic developments: an aging population, decreasing mortality of patients with acute myocardial infarction, and improved treatment of patients with angina pectoris and hypertension.2 In addition, survival in patients with CHF has improved since the introduction of angiotensin converting enzyme (ACE) inhibitors.CHF is clinically characterised by periods of remission and exacerbation. Readmission rates of up to 25% within six months after a previous hospital discharge for CHF have been reported in patients older than 65 years.3 4 Relapse of CHF in patients with previously stable compensated heart failure may be caused by deteriorating ventricular function, but several precipitating factors have been suggested. Some precipitating factors can be regarded as potentially preventable. Research on precipitating factors leading to relapses of CHF, however, is scarce.5 6 Nevertheless, timely identification of potential precipitating factors may oVer an important advantage in eVorts to reduce morbidity and the number of hospital admissions attributed to the syndrome of CHF.We conducted a search of the MEDLINE database from 1966 to December 1997 and used lateral references to review the li...
“…The cardiovascular effect of cigarette smoking has been reported by many investigators [9][10][11]. They ob served that cigarette smoking has an acute effect upon the circulation, including an increase in both HR and BP, although it may have a different effect with long-term exposure [12], Moreover, these effects were mainly relat ed to the amount of tobacco smoked, the habits of inhal ing the smoke and the type of tobacco.…”
The plasma nicotine level and hemodynamic parameters were evaluated after cigarette smoking in young (group I, 17 men) and middle-aged habitual smokers (group II, 17 men). The amount of increase in plasma nicotine concentration after smoking was related to the percent change of mean blood pressure in both groups. The total peripheral vascular resistance index (TPRI) increased significantly at 10 min after smoking and reduced thereafter in group I, whereas the TPRI increased till 30 min after in group II. Thus, smoking raised the TPRI for a longer time in the middle-aged subjects due to a decrease in aortic elasticity with aging.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.